Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 208

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 208
---
 ​ 
 ​ | Liminatus(Historical) 
 ​                     | ​ |          ​ | ​ | ​ 
 ​ | ​ 
 ​ | Iris(Historical) 
 ​                | ​ |         ​ | ​ | ​ 
 ​ | ​ 
 ​ | TransactionAccountingAdjustments(Assuming NoAdditionalRedemptions)(Note 3) 
 ​                                                                          | ​ |    ​ | ​ | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | ​   
 ​   | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | Pro FormaCombined(AssumingNo AdditionalRedemptions) 
 ​                                                   | ​ |          ​ | ​ | ​ 
 ​ | ​ 
 ​ | TransactionAccountingAdjustments(AssumingMaximumRedemptions)(Note 3) 
 ​                                                                    | ​ | ​ | ​ | ​ 
 ​ | ​ 
 ​ | Pro FormaCombined(AssumingMaximumRedemptions) 
 ​                                             | ​ |          ​ | ​ | ​ 
 ​ |
|:----------------------------------------------------------------------|:--|:--|:----------------------|:--|-----------:|:--|:--|:--|:-----------------|:--|----------:|:--|:--|:--|:---------------------------------------------------------------------------|:--|-----:|:--|:--|:--|:--|:--|:----|:--|:--|:--|:----------------------------------------------------|:--|-----------:|:--|:--|:--|:---------------------------------------------------------------------|:--|:--|:--|:--|:--|:----------------------------------------------|:--|-----------:|:--|:--|
| General and administrative                                            | ​ | ​ | ​                     | $ |        478 | ​ | ​ | ​ | ​                | $ |     2,384 | ​ | ​ | ​ | ​                                                                          | ​ |    ​ | ​ | ​ | ​ | ​ | ​ | ​   | ​ | ​ | ​ | ​                                                   | $ |      2,862 | ​ | ​ | ​ | ​                                                                    | ​ | ​ | ​ | ​ | ​ | ​                                             | $ |      2,862 | ​ | ​ |
| Research and development                                              | ​ | ​ | ​                     | ​ |      2,685 | ​ | ​ | ​ | ​                | ​ |         — | ​ | ​ | ​ | ​                                                                          | ​ |    ​ | ​ |